Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I

Respiratory complex I inhibition by drugs and other chemicals has been implicated as a frequent mode of mitochondria-mediated cell injury. However, the exact mechanisms leading to the activation of cell death pathways are incompletely understood. This study was designed to explore the relative cont...

Full description

Bibliographic Details
Main Authors: Naoki Imaizumi, Kang Kwang Lee, Carmen Zhang, Urs A. Boelsterli
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231715000063
id doaj-724c956be5c74257a702e577874aa26c
record_format Article
spelling doaj-724c956be5c74257a702e577874aa26c2020-11-25T01:32:02ZengElsevierRedox Biology2213-23172015-04-014C27928810.1016/j.redox.2015.01.005Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex INaoki Imaizumi0Kang Kwang Lee1Carmen Zhang2Urs A. Boelsterli3Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA Respiratory complex I inhibition by drugs and other chemicals has been implicated as a frequent mode of mitochondria-mediated cell injury. However, the exact mechanisms leading to the activation of cell death pathways are incompletely understood. This study was designed to explore the relative contributions to cell injury of three distinct consequences of complex I inhibition, i.e., impairment of ATP biosynthesis, increased formation of superoxide and, hence, peroxynitrite, and inhibition of the mitochondrial protein deacetylase, Sirt3, due to imbalance of the NADH/NAD+ ratio. We used the antiviral drug efavirenz (EFV) to model drug-induced complex I inhibition. Exposure of cultured mouse hepatocytes to EFV resulted in a rapid onset of cell injury, featuring a no-effect level at 30 µM EFV and submaximal effects at 50 µM EFV. EFV caused a concentration-dependent decrease in cellular ATP levels. Furthermore, EFV resulted in increased formation of peroxynitrite and oxidation of mitochondrial protein thiols, including cyclophilin D (CypD). This was prevented by the superoxide scavenger, Fe-TCP, or the peroxynitrite decomposition catalyst, Fe-TMPyP. Both ferroporphyrins completely protected from EFV-induced cell injury, suggesting that peroxynitrite contributed to the cell injury. Finally, EFV increased the NADH/NAD+ ratio, inhibited Sirt3 activity, and led to hyperacetylated lysine residues, including those in CypD. However, hepatocytes isolated from Sirt3-null mice were protected against 40 µM EFV as compared to their wild-type controls. In conclusion, these data are compatible with the concept that chemical inhibition of complex I activates multiple pathways leading to cell injury; among these, peroxynitrite formation may be the most critical. http://www.sciencedirect.com/science/article/pii/S2213231715000063Sirt3EfavirenzComplex I inhibitionMitochondriaPeroxynitriteDrug-induced liver injury (DILI)
collection DOAJ
language English
format Article
sources DOAJ
author Naoki Imaizumi
Kang Kwang Lee
Carmen Zhang
Urs A. Boelsterli
spellingShingle Naoki Imaizumi
Kang Kwang Lee
Carmen Zhang
Urs A. Boelsterli
Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I
Redox Biology
Sirt3
Efavirenz
Complex I inhibition
Mitochondria
Peroxynitrite
Drug-induced liver injury (DILI)
author_facet Naoki Imaizumi
Kang Kwang Lee
Carmen Zhang
Urs A. Boelsterli
author_sort Naoki Imaizumi
title Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I
title_short Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I
title_full Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I
title_fullStr Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I
title_full_unstemmed Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I
title_sort mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex i
publisher Elsevier
series Redox Biology
issn 2213-2317
publishDate 2015-04-01
description Respiratory complex I inhibition by drugs and other chemicals has been implicated as a frequent mode of mitochondria-mediated cell injury. However, the exact mechanisms leading to the activation of cell death pathways are incompletely understood. This study was designed to explore the relative contributions to cell injury of three distinct consequences of complex I inhibition, i.e., impairment of ATP biosynthesis, increased formation of superoxide and, hence, peroxynitrite, and inhibition of the mitochondrial protein deacetylase, Sirt3, due to imbalance of the NADH/NAD+ ratio. We used the antiviral drug efavirenz (EFV) to model drug-induced complex I inhibition. Exposure of cultured mouse hepatocytes to EFV resulted in a rapid onset of cell injury, featuring a no-effect level at 30 µM EFV and submaximal effects at 50 µM EFV. EFV caused a concentration-dependent decrease in cellular ATP levels. Furthermore, EFV resulted in increased formation of peroxynitrite and oxidation of mitochondrial protein thiols, including cyclophilin D (CypD). This was prevented by the superoxide scavenger, Fe-TCP, or the peroxynitrite decomposition catalyst, Fe-TMPyP. Both ferroporphyrins completely protected from EFV-induced cell injury, suggesting that peroxynitrite contributed to the cell injury. Finally, EFV increased the NADH/NAD+ ratio, inhibited Sirt3 activity, and led to hyperacetylated lysine residues, including those in CypD. However, hepatocytes isolated from Sirt3-null mice were protected against 40 µM EFV as compared to their wild-type controls. In conclusion, these data are compatible with the concept that chemical inhibition of complex I activates multiple pathways leading to cell injury; among these, peroxynitrite formation may be the most critical.
topic Sirt3
Efavirenz
Complex I inhibition
Mitochondria
Peroxynitrite
Drug-induced liver injury (DILI)
url http://www.sciencedirect.com/science/article/pii/S2213231715000063
work_keys_str_mv AT naokiimaizumi mechanismsofcelldeathpathwayactivationfollowingdruginducedinhibitionofmitochondrialcomplexi
AT kangkwanglee mechanismsofcelldeathpathwayactivationfollowingdruginducedinhibitionofmitochondrialcomplexi
AT carmenzhang mechanismsofcelldeathpathwayactivationfollowingdruginducedinhibitionofmitochondrialcomplexi
AT ursaboelsterli mechanismsofcelldeathpathwayactivationfollowingdruginducedinhibitionofmitochondrialcomplexi
_version_ 1725083640990269440